Hipertension y Riesgo Vascular最新文献

{"title":"Metabolic biomarkers and cardiovascular risk stratification in hypertension","authors":"D. Piskorz,&nbsp;L. Keller,&nbsp;L. Citta,&nbsp;G. Tissera,&nbsp;L. Mata,&nbsp;L. Bongarzoni","doi":"10.1016/j.hipert.2024.06.003","DOIUrl":"10.1016/j.hipert.2024.06.003","url":null,"abstract":"<div><h3>Introduction</h3><p>Cardiovascular risk calculators (CRC) are not locally validated and calibrated. Surrogate biomarkers of insulin resistance had identified subjects at higher risk of type 2 diabetes and cardiovascular disease.</p></div><div><h3>Aim</h3><p>Establish the frequency of surrogate biomarkers of insulin resistance and their correlation with CRC in primary prevention non-diabetic hypertensive subjects.</p></div><div><h3>Methods</h3><p>This is an observational registry with a prospective consecutive outpatient's sample. The TyG index (TyGi) was calculated as logarithm (Ln) of (fasting triglycerides [mg/dl]<!--> <!-->×<!--> <!-->fasting plasma glucose [mg/dl]/2). Patients were stratified according to quartiles of TyGi. Pearson correlation coefficient between TyGi and other relevant variables was evaluated.</p></div><div><h3>Results</h3><p>Four hundred six patients were included with a mean age 55.9<!--> <!-->±<!--> <!-->13 years, 231 p (56.9%) males. The mean TyGi was 8.667<!--> <!-->±<!--> <!-->0.53. Patients in the highest quartiles of TyGi had significantly higher median difference between expected and actual ASCVD risk (<em>p</em> <!-->=<!--> <!-->0.02), higher frequency of AHA/ACC Pooled Cohort Equation &gt;7.5% (<em>p</em> <!-->&lt;<!--> <!-->0.005), and higher levels of metabolic biomarkers such as median triglyceridemia/HDL cholesterol ratio (TG/HDL) (<em>p</em> <!-->&lt;<!--> <!-->0.0005), glycaemia and A1C (<em>p</em> <!-->&lt;<!--> <!-->0.001 and <em>p</em> <!-->=<!--> <!-->0.02, respectively). The correlation between TyGi and TG/HDL was highly significant (<em>r</em> <!-->=<!--> <!-->0.7076; <em>r</em>² <!-->=<!--> <!-->0.5007; <em>p</em> <!-->&lt;<!--> <!-->0.0001), and intermediate with non-HDL cholesterol (<em>r</em> <!-->=<!--> <!-->0.4553, <em>r</em>² <!-->=<!--> <!-->0.2073; <em>p</em> <!-->&lt;<!--> <!-->0.0001).</p></div><div><h3>Conclusions</h3><p>Non-diabetic hypertensive patients with high TyGi, a surrogate biomarker of insulin resistance, had a higher 10-year cardiovascular risk by AHA/ACC Pooled Cohort Equation. TyGi is statistically and significantly correlated with other biomarkers of insulin resistance. TyGi could be a reliable biomarker in clinical practice to stratify cardiovascular risk.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"41 3","pages":"Pages 162-169"},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141752974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"HT and uric acid, uric acid and HT: Is hyperuricemia a new vascular risk factor to consider?","authors":"Mencia Benitez Camps","doi":"10.1016/j.hipert.2024.06.001","DOIUrl":"10.1016/j.hipert.2024.06.001","url":null,"abstract":"","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"41 3","pages":"Pages 143-144"},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141793693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"","authors":"","doi":"10.1016/j.hipert.2024.05.001","DOIUrl":"10.1016/j.hipert.2024.05.001","url":null,"abstract":"","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"41 3","pages":"Pages 203-204"},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141950434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Antihipertensivos, presión positiva continua en la vía aérea y apnea obstructiva del sueño","authors":"","doi":"10.1016/j.hipert.2024.02.005","DOIUrl":"https://doi.org/10.1016/j.hipert.2024.02.005","url":null,"abstract":"","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"41 2","pages":"Pages 139-140"},"PeriodicalIF":0.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140540629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is proteinuria an important fact concerning the nephroprotective effect of renin-angiotensin system inhibitors?","authors":"J.M. Galceran","doi":"10.1016/j.hipert.2024.02.007","DOIUrl":"10.1016/j.hipert.2024.02.007","url":null,"abstract":"","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"41 2","pages":"Pages 75-77"},"PeriodicalIF":0.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140177011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Title Page","authors":"","doi":"10.1016/S1889-1837(24)00073-4","DOIUrl":"https://doi.org/10.1016/S1889-1837(24)00073-4","url":null,"abstract":"","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"41 ","pages":"Page i"},"PeriodicalIF":0.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140880254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Emergencia hipertensiva como debut de síndrome de Cushing paraneoplásico","authors":"E. Rubio González,&nbsp;M. de Valdenebro Recio,&nbsp;M.I. Galán Fernández","doi":"10.1016/j.hipert.2023.10.003","DOIUrl":"10.1016/j.hipert.2023.10.003","url":null,"abstract":"<div><p>We present the case of a patient with a history of renal-vascular hypertension treated with stent one year previously, who attended the emergency room due to hypertensive emergency and dyspnea. Once the first suspicion of renal artery restenosis was ruled out with CT angiography, the study was completed, confirming the diagnosis of lung cancer through imaging and pathological anatomy. In the hormonal study, elevation of ACTH, hypercortisolism and analytical data of hyperaldosteronism were detected. With the final diagnosis of Cushing's syndrome secondary to ectopic production of ACTH, medical treatment was started, without being able to receive anything else due to the death of the patient after a few days.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"41 2","pages":"Pages 135-138"},"PeriodicalIF":0.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140177009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Estudio de prevalencia, conocimiento y control de la hipertensión arterial en barrios vulnerables de Argentina","authors":"W.G. Espeche ,&nbsp;M. Marin ,&nbsp;C. Romero ,&nbsp;N. Renna ,&nbsp;S. Vissani ,&nbsp;G. Blanco ,&nbsp;S.P. Pantalena ,&nbsp;D. Cesario ,&nbsp;E. Diez ,&nbsp;C. Grasso ,&nbsp;E. Garzon ,&nbsp;J. Barochiner ,&nbsp;M. Ruise ,&nbsp;J. Minetto ,&nbsp;N. Mazzei ,&nbsp;E. Ramirez ,&nbsp;M. Rojas ,&nbsp;P. Carrera Ramos ,&nbsp;M.S. Gimenez ,&nbsp;M. Rivarola ,&nbsp;M.R. Salazar","doi":"10.1016/j.hipert.2024.02.001","DOIUrl":"10.1016/j.hipert.2024.02.001","url":null,"abstract":"<div><h3>Introduction</h3><p>Hypertension (HTN) represents the primary individual risk factor, contributing significantly to the global burden of cardiovascular diseases (CVD). In our country, epidemiological research has highlighted substantial variations in the prevalence of these risk factors across different populations. However, there is a lack of epidemiological studies assessing exclusive cardiovascular risk factors within vulnerable neighborhoods characterized by extremely limited economic resources, sociocultural challenges, and inadequate healthcare access.</p></div><div><h3>Methods</h3><p>A multicenter cross-sectional observational study was conducted among individuals residing in economically deprived and marginalized communities, including informal settlements and underprivileged neighborhoods. Simple random sampling of households was employed.</p><p>Blood pressure measurements, anthropometric assessments, and epidemiological, economic, and sociocultural questionnaires were administered.</p><p>Results encompass prevalence rates, awareness levels, and blood pressure control across diverse regions. Logistic regression was utilized to identify independent variables influencing primary outcomes.</p></div><div><h3>Results</h3><p>A total of 989 participants were analyzed. The overall prevalence of hypertension was 48.2%. About 82% had a body mass index (BMI) &gt;<!--> <!-->25. Approximately 45.3% had less than 6 years of formal education. Independent association was established between education levels below 6 years and higher hypertension prevalence.</p><p>Among hypertensive individuals, 44% were unaware of their condition, with only 17.2% achieving control, correlated with having health insurance and a higher educational background. Merely 24% were receiving combined therapy.</p></div><div><h3>Conclusion</h3><p>The prevalence of hypertension within vulnerable neighborhoods is alarmingly high, surpassing rates in other social strata. Knowledge, treatment, and control levels of hypertension are suboptimal, comparable to other populations. Inadequate use of combination therapy was observed. This study underscores the urgent need for targeted interventions addressing cardiovascular risk factors in poor areas to mitigate the burden of CVD.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"41 2","pages":"Pages 78-86"},"PeriodicalIF":0.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139991439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"La importancia de la genética en el estudio de la hipertrigliceridemia","authors":"A. Rosales-Castillo,&nbsp;A. Bustos-Merlo,&nbsp;J. Escobar Sevilla","doi":"10.1016/j.hipert.2023.12.001","DOIUrl":"10.1016/j.hipert.2023.12.001","url":null,"abstract":"<div><p>Hypertriglyceridemia encompasses a set of lipid disorders common in clinical practice, generally defined as a fasting concentration above 150<!--> <!-->mg/dL. There are various classifications of the severity of hypertriglyceridaemia based on serum values, with levels generally considered moderate when below 500<!--> <!-->mg/dL and severe when above 1000<!--> <!-->mg/dL. Its importance lies in its association with other alterations in the lipid profile, contributing to increased cardiovascular risk and increased risk of acute pancreatitis, mainly with concentrations above 500<!--> <!-->mg/dL.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"41 2","pages":"Pages 132-134"},"PeriodicalIF":0.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140111747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hypertensive states of pregnancy","authors":"E. Rubio Gonzalez ,&nbsp;A.M. Huerta Arroyo ,&nbsp;F. Garcia Benasach ,&nbsp;T. Gijon Conde","doi":"10.1016/j.hipert.2023.11.006","DOIUrl":"10.1016/j.hipert.2023.11.006","url":null,"abstract":"<div><p>Hypertensive disorders in pregnancy (HDP) remain a leading cause of pregnancy-related maternal and foetal morbidity and mortality worldwide, including chronic hypertension, gestational hypertension, and pre-eclampsia.</p><p>Affected women and newborns also have an increased risk of cardiovascular disease later in life, independent of traditional cardiovascular disease risks. Despite these risks, recommendations for optimal diagnosis and treatment have changed little in recent decades, probably due to fear of the foetal repercussions of decreased blood pressure and possible drug toxicity.</p><p>In this document we review the diagnostic criteria and classification of (HDP), as well as important aspects regarding pathophysiology and early detection that allows early identification of women at risk, with the aim of preventing both immediate and long-term consequences. Prophylactic treatment with aspirin is also reviewed early and a therapeutic approach is carried out that involves close maternal and foetal monitoring, and if necessary, the use of safe drugs in each situation.</p><p>This review aims to provide an updated vision for the prevention, diagnosis, and treatment of HDP that is useful in our usual clinical practice.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"41 2","pages":"Pages 118-131"},"PeriodicalIF":0.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140177010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}